Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The authors hypothesize that the SARS-CoV-2 virus can affect the kidneys, causing them to be damaged. The present study aims to explain the mechanisms of kidney injury in patients diagnosed with COVID-19.
In December 2019, an outbreak of the 2019 novel coronavirus disease (COVID-19) caused by the SARS coronavirus 2 (SARS-CoV-2) occurred in Wuhan, China. It has spread rapidly to other areas in China and worldwide. The most common manifestations of COVID-19 included fever, dry cough, dyspnea, myalgia, fatigue and radiographic evidence of pneumonia. Complications (acute respiratory distress syndrome, shock, acute cardiac injury, secondary infection, and acute kidney injury) and death may occur in severe cases. Recent reports showed that extrapulmonary symptoms (intestinal symptoms in 10-20% of patients) and renal failure in some patients may be associated with the interaction of the virus with angiotensin-converting enzyme 2 (ACE-2) receptors in other organs. It was suggested that ACE-2 expression in the kidneys can be the cause of kidney injury occurring in a number of patients with SARS-CoV-2.However, ACE-2 is not the only possible cause of kidney injury - sepsis-related cytokine storm can also lead to damage of kidney parenchyma.
The present study aims to explain the mechanisms of kidney injury in patients diagnosed with COVID-19.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Mild COVID-19 | Pneumonia without respiratory failure |
| |
| Moderate COVID-19 up to 60 years | Respiratory frequency ≥30/minute, blood oxygen saturation≤93% |
| |
| Moderate COVID-19 over 60 years old and severe COVID-19 | Pneumonia with respiratory distress syndrome |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| mRNA in urine test | Diagnostic Test | Assessment of renal function, expression of viral RNA in urine and assessment of radiological changes will be performed |
|
| Measure | Description | Time Frame |
|---|---|---|
| The effect of COVID-19 severity on the severity of renal failure | estimated glomerular filtration rate (eGFR), ml/min, in groups with mild, moderate and severe COVID-19 | 2 months |
| Measure | Description | Time Frame |
|---|---|---|
| The expression of viral RNA in the urine with the severity of renal failure | viral RNA concentration in urine, ME/ml | 2 months |
| The severity of microalbuminuria in patients with COVID-19 of different conditions and renal failure |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Males and females with confirmed viral pneumonia
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Dmitry Enikeev, M.D., Ph.D. | Sechenov University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Sechenov University. | Moscow | 119991 | Russia |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000086382 | COVID-19 |
| D018352 | Coronavirus Infections |
| ID | Term |
|---|---|
| D011024 | Pneumonia, Viral |
| D011014 | Pneumonia |
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
Not provided
Not provided
| ID | Term |
|---|---|
| D016482 | Urinalysis |
| ID | Term |
|---|---|
| D019963 | Clinical Chemistry Tests |
| D019411 | Clinical Laboratory Techniques |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
Not provided
Not provided
Not provided
Not provided
Not provided
Blood,urine, sputum. Renal tissue only from post-portem kidney biopsies.
|
albumine excretion with urine, g/ml
| 2 months |
| Assessment of the severity of renal impairment in patients who died from COVID-19 | estimated glomerular filtration rate (eGFR), ml/min | 2 months |
| Estimation of the duration of urinary viral RNA isolation in patients undergoing COVID-19 | Duration of viral RNA detection in urine by PCR, weeks | 2 months |
| Expression of ACE-2 receptors in the kidneys of patients with renal failure who died from COVID-19 | expression of ACE-2 by imminohistochemistry at autopsy specimen | 2 months |
| D014777 |
| Virus Diseases |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012327 | RNA Virus Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D003950 | Diagnostic Techniques, Urological |
| D008919 | Investigative Techniques |